PLUR
Pluri, Inc.
NASDAQ · Healthcare · Biotechnology · IL
$1.08
+0.00%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 10, 2026
- EPS actual
- -$0.54
- EPS estimate
- -$0.66
- Revenue actual
- $335.0K
- Revenue estimate
- $655.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +9.4%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 10, 2026 | -$0.66 | -$0.54 | Beat 18.18% | $335.0K |
| May 14, 2026 | -$0.66 | -$0.55 | Beat 16.67% | $167.0K |
| Feb 12, 2026 | -$0.65 | -$0.71 | Miss -9.23% | $198.0K |
| Nov 12, 2025 | -$0.74 | -$0.65 | Beat 12.16% | $316.0K |
| Sep 17, 2025 | -$0.65 | -$2.62 | Miss -303.08% | $398.0K |
| Sep 18, 2024 | $0.16 | -$2.98 | Miss -1962.50% | — |
| May 9, 2024 | -$0.24 | -$1.01 | Miss -320.83% | — |
| Nov 13, 2023 | — | -$0.96 | — | $54.0K |
| Sep 12, 2023 | -$2.48 | -$1.20 | Beat 51.61% | $111.0K |
| Feb 13, 2023 | -$2.56 | -$1.92 | Beat 25.00% | $2.0K |
| Nov 10, 2022 | -$0.32 | -$1.52 | Miss -375.00% | $87.0K |
| Sep 21, 2022 | -$0.35 | -$2.24 | Miss -540.00% | $234.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026